Orlando, FL -- (SBWIRE) -- 10/23/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Amarin Corporation plc (ADR) (NASDAQ:AMRN), Dendreon Corporation (NASDAQ:DNDN).
Amarin Corporation plc (ADR) (NASDAQ:AMRN) stock dropped 0.87% to $2.28. The company, on Oct. 22, announced plans to reduce operating expenses by eliminating approximately fifty percent of its staff positions worldwide following the recent recommendation of the U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee against the potential Vascepa® (icosapent ethyl) label expansion. Amarin will continue its dialogue with FDA regarding the ANCHOR data. Given the outcome of the advisory committee meeting, Amarin feels this shift in staffing is the appropriate corporate action.
Are investors worried about the recent updates with AMRN? Find out with a free trend analysis HERE
Dendreon Corporation (NASDAQ:DNDN) shares fell 2.92% and closed at $2.33. DNDN‘s stock had its “neutral” rating reaffirmed by Zacks in a research report issued to clients and investors on Oct. 7. They currently have a $3.00 target price on the stock. Zacks‘ price target would indicate a potential upside of 7.91% from the company’s current price.
Additionally, the company announced that management will host a conference call on Tuesday, November 12, 2013, at 9:00 a.m. EST to review third quarter financial results.
Is DNDN going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)